The human rotavirus vaccine market is expected to witness market growth at a rate of 11.21% in the forecast period of 2021 to 2028. Data Bridge Market Research report on human rotavirus vaccine market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.
Human Rotavirus Vaccine Market Scope and Market Size
On the basis of type, the human rotavirus vaccine market is segmented into rotarix, rotateq, rotavac, rotavin-M1, Lanzhou lamb, others.
On the basis of application, the human rotavirus vaccine market is segmented into Hospitals and Clinics, Academic and Research
On the basis of end users, the human rotavirus vaccine market is segmented into hospitals and clinics, academic and research, others.
Click Here to Get Latest Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-human-rotavirus-vaccine-market
Human Rotavirus Vaccine Market Country Level Analysis
The countries covered in the human rotavirus vaccine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Human Rotavirus Vaccine Market Share Analysis
The human rotavirus vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to human rotavirus vaccine market.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-human-rotavirus-vaccine-market
Key Players –
The major players covered in the human rotavirus vaccine market report are Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED, among other domestic and global players.
MAJOR TOC OF THE REPORT
Part One: Human Rotavirus Vaccine Market Overview
Part Two: Manufacturers Profiles
Part Three: Global Human Rotavirus Vaccine Market Competition, by Players
Part Four: Global Human Rotavirus Vaccine Market Size by Regions
Part Five: Global Human Rotavirus Vaccine Market Revenue by Countries
Part Six: Global Human Rotavirus Vaccine Market Revenue by Type
Part Seven: Global Human Rotavirus Vaccine Market Revenue by Application
Part Eight: Global Human Rotavirus Vaccine Market Revenue by Geography
Part Nine: Global Human Rotavirus Vaccine Market Revenue by Geography
Part Ten: Global Human Rotavirus Vaccine Market Revenue by Geography
Part Eleven: Global Human Rotavirus Vaccine Market Revenue by Geography
Get Detail TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-human-rotavirus-vaccine-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports @
Human Rotavirus Vaccine Market Information By Type Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others by End Users Hospitals & Clinics, Academic and Research, Others - Global Forecast Till 2023 Segments:The global Human Rotavirus Vaccine Market has been segmented on the basis of type and end users.Based on type, the market has been segmented as Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb and others.Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.Key Players in the Global Human rotavirus vaccine MarketSome of key players profiled in the report are Bharat Biotech, Merck & Co., Inc., GlaxoSmithKline plc.
Multinational pharmaceutical drug company and others.The report for Global Human rotavirus vaccine market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age.The vaccine first became available in the United States in 2006.
Rotavirus is a double-stranded RNA virus of the family Reoviridae and is transmitted through the faecal-oral route.
It infects the cell lining of the small intestine and causes gastroenteritis.According to National Center for Biotechnology Information, rotavirus related diarrhoea was responsible for killing about 600,000 children in 2015, with more than 80% of all rotavirus-related deaths occurring in South Asia and sub-Saharan Africa.The market drivers for rotavirus vaccine market are its safety profile including use in HIV/AIDS patients, growing number of immunity-compromised individuals, increasing geriatric population, growing population and live births etc.
The market restraints are risks such as immune reaction, babies who have had intussusception, low healthcare expenditure in developing regions, cleanliness initiatives by NGOs and health awareness creation to eradicate the prevalence of this virus etc.The global human rotavirus vaccine market is expected to reach US$ 12.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 11.2 % during the forecast period 2017-2023.Regional analysis: The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care.
